HLA-G protein processing and transport to the cell surface

Cellular and Molecular Life Sciences

Volumn 59, Issue 9, 2002, Pages 1460-1466

  Moreau, P ^a   Rousseau, P ^a   Rouas Freiss, N ^a   Le Discorde, M ^a   Dausset, J ^b   Carosella, E D ^b  

^a DIF   (France)

^b Fondation Jean Dausset   (France)

Author keywords

Function; HLA G isoform; Intracellular traffic

Indexed keywords

HLA ANTIGEN CLASS 1; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G2 ANTIGEN; HLA G3 ANTIGEN; HLA G4 ANTIGEN; HLA G5 ANTIGEN; HLA G6 ANTIGEN; HLA G7 ANTIGEN; ISOPROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANTIGEN BINDING; CELL SPECIFICITY; CELL SURFACE; CELL TRANSPORT; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INTRACELLULAR TRANSPORT; LIGAND BINDING; MEMBRANE BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUALITY CONTROL; REVIEW; TRANSPORT KINETICS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 0036710903     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8521-8     Document Type: Review

References (67)

1. Geraghty D. E., Koller B. H. and Orr H. T. (1987) A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc. Natl. Acad. Sci. USA 84: 9145-9149
2. Geraghty D. E., Koller B. H., Hansen J. A. and Orr H. T. (1992) The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments. J. Immunol. 149: 1934-1946
3. Kirszenbaum M., Moreau P., Gluckman E., Dausset J. and Carosella E. D. (1994) An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA 91: 4209-4213
4. Fujii T., Ishitani A. and Geraghty D. E. (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153: 5516-5524
5. Moreau P., Carosella E., Teyssier M., Prost S., Gluckman E., Dausset J. et al. (1995) Soluble HLA-G molecule: An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum. Immunol. 43: 231-236
6. Paul P., Cabestre F. A., Ibrahim E. C., Lefebvre S., Khalil-Daher I., Vazeux G. et al. (2000) Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum. Immunol. 61: 1138-1149
7. Matte C., Lacaille J., Zijenah L., Ward B. and Roger M. (2000) HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum. Immunol. 61: 1150-1156
8. Hviid T. V., Christiansen O. B., Johansen J. K., Hviid U. R., Lundegaard C., Moller C. et al. (2001) Characterization of a new HLA-G allele encoding a nonconservative amino acid substitution in the alpha3 domain (exon 4) and its relevance to certain complications in pregnancy. Immunogenetics 53: 48-53
9. Suarez M. B., Morales P., Castro M. J., Fernandez V., Varela P., Alvarez M. et al. (1997) A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics 45: 464-465
10. McMaster M. T., Librach C. L., Zhou Y., Lim K. H., Janatpour M. J., DeMars R. et al. (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154: 3771-3778
11. Hammer A., Hutter H., Blaschitz A., Mahnert W., Hartmann M., Uchanska-Ziegler B. et al. (1997) Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am. J. Reprod. Immunol. 37: 161-171
12. Blaschitz A., Lenfant F., Mallet V., Hartmann M., Bensussan A., Geraghty D. E. et al. (1997) Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 27: 3380-3388
13. Crisa L., McMaster M. T., Ishii J. K., Fisher S. J. and Salomon D. R. (1997) Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J. Exp. Med. 21: 289-298
14. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J. et al. (1999) IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 11: 803-811
15. Spencer J. V., Lockridge K. M., Barry P. A., Lin G., Tsang M., Penfold M. E. et al. (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76: 1285-1292
16. Yang Y., Chu W., Geraghty D. E. and Hunt J. S. (1996) Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J. Immunol. 156: 4224-4231
17. Amiot L., Onno M., Drenou B., Monvoisin C. and Fauchet R. (1998) HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum. Immunol. 59: 524-528
18. Lefebvre S., Berrih-Aknin S., Adrian F., Moreau P., Poea S., Gourand L. et al. (2001) A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J. Biol. Chem. 276: 6133-6199
19. Paul P., Cabestre F. A., Le Gal F. A., Khalil-Daher I., Le Danff C., Schmid M. et al. (1999) Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res. 59: 1954-1960
20. Urosevic M., Kurrer M. O., Kamarashev J., Mueller B., Weder W., Burg G. et al. (2001) Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am. J. Pathol. 159: 817-824
21. Ibrahim E. C., Guerra N., Lacombe M. J., Angevin E., Chouaib S., Carosella E. D. et al. (2001) Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res. 61: 6838-6845
22. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P. and Fauchet R. (2000) Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection. J. Immunol. 164: 6424-6434
23. Lozano J. M., Gonzalez R., Kindelan J. M., Rouas-Freiss N., Caballos R., Dausset J. et al. (2002) Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16: 347-351
24. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J. and Carosella E. D. (2000) Implication of HLA-G molecule in heart-graft acceptance. Lancet 355: 2138
25. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L. et al. (2001) HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells? Am. J. Pathol. 159: 71-77
26. Khosrotehrani K., Le Danff C., Reynaud-Mendel B., Dubertret L., Carosella E. D. and Aractingi S. (2001) HLA-G expression in atopic dermatitis. J. Invest. Dermatol. 117: 750-752
27. Carosella E. D., Moreau P., Aractingi S. and Rouas-Freiss N. (2001) HLA-G: A shield against inflammatory aggression. Trends Immunol. 22: 553-555
28. Solier C., Mallet V., Lenfant F., Bertrand A., Huchenq A. and Le Bouteiller P. (2001) HLA-G unique promoter region: Functional implications. Immunogenetics 53: 617-625
29. Braud V. M., Allan D. S. and McMichael A. J. (1999) Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11: 100-108
30. Carosella E. D., Paul P., Moreau P. and Rouas-Freiss N. (2000) HLA-G and HLA-E: Fundamental and pathophysiological aspects. Immunol. Today 21: 532-534
31. Bainbridge D. R., Ellis S. A. and Sargent I. L. (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol. 48: 17-26
32. Lila N., Rouas-Freiss N., Dausset J., Carpentier A. and Carosella E. D. (2001) Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 98: 12150-12155
33. Le Bouteiller P., Rodriguez A. M., Mallet V., Girr M., Guillaudeux T. and F. Lenfant (1996) Placental expression of HLA class I genes. Am. J. Reprod. Immunol. 35: 216-225
34. Forte P., Pazmany L., Matter-Reissmann U. B., Stussi G., Schneider M. K. and Seebach J. D. (2001) HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J. Immunol. 167: 6002-6008
35. Neefjes J. J. and Momburg F. (1993) Cell biology of antigen presentation. Curr. Opin. Immunol. 5: 27-34
36. Schust D. J., Tortorella D. and Ploegh H. L. (1999) HLA-G and HLA-C at the feto-maternal interface: Lessons learned from pathogenic viruses. Semin. Cancer Biol. 9: 37-46
37. Lee N., Malacko A. R., Ishitani A., Chen M. C., Bajorath J., Marquardt H. et al. (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3: 591-600
38. Diehl M., Munz C., Keilholz W., Stevanovic S., Holmes N., Loke Y. W. et al. (1996) Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6: 305-314
39. Le Bouteiller P. and Blaschitz A. (1999) The functionality of HLA-G is emerging. Immunol. Rev. 167: 233-244
40. Gobin S. J., Wilson L., Keijsers V. and Van den Elsen P. J. (1997) Antigen processing and presentation by human trophoblast-derived cell lines. J. Immunol. 158: 3587-3592
41. Fruh K., Ahn K., Djaballah H., Sempe P., Endert P. M. van, Tampe R. et al. (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418
42. Easterfield A. J., Austen B. M. and Westwood O. M. (2001) Inhibition of antigen transport by expression of infected cell peptide 47 (ICP47) prevents cell surface expression of HLA in choriocarcinoma cell lines. J. Reprod. Immunol. 50: 19-40
43. Schust D. J., Hill A. B. and Ploegh H. L. (1996) Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J. Immunol. 157: 3375-3380
44. Munz C., Stevanovic S. and Rammensee H. G. (1999) Peptide presentation and NK inhibition by HLA-G. J. Reprod. Immunol. 43: 139-155
45. Jun Y., Kim E., Jin M., Sung H. C., Han H., Geraghty D. E. et al. (2000) Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J. Immunol. 164: 805-811
46. Park B., Lee S., Kim E., Chang S., Jin M. and Ahn K. (2001) The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 15: 213-224
47. McMaster M., Zhou Y., Shorter S., Kapasi K., Geraghty D., Lim K. H. et al. (1998) HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J. Immunol. 160: 5922-5928
48. Schust D. J., Tortorella D., Seebach J., Phan C. and Ploegh H. L. (1998) Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188: 497-503
49. Davis D. M., Reyburn H. T., Pazmany L., Chiu I., Mandelboim O. and Strominger J. L. (1997) Impaired spontaneous endocytosis of HLA-G. Eur. J. Immunol. 27: 2714-2719
50. Teasdale R. D. and Jackson M. R. (1996) Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu. Rev. Cell. Dev. Biol. 12: 27-54
51. Menier C., Riteau B., Dausset J., Carosella E. D. and Rouas-Freiss N. (2000) HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum. Immunol. 61: 1118-1125
52. Mallet V., Proll J., Solier C., Aguerre-Girr M., DeRossi M., Loke Y. W. et al. (2000) The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells. Hum. Immunol. 61: 212-224
53. Bainbridge D. R., Ellis S. A. and Sargent I. L. (2000) The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface. J. Reprod. Immunol. 47: 1-16
54. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J. and Carosella E. D. (2001) HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J. Immunol. 166: 5018-5026
55. Kim H. S., Garcia J., Exley M., Johnson K. W., Balk S. P. and Blumberg R. S. (1999) Biochemical characterization of CDld expression in the absence of beta2-microglobulin. J. Biol. Chem.274: 9289-9295
56. Kleijnen M. F., Huppa J. B., Lucin P., Mukherjee S., Farrell H., Campbell A. E. et al. (1997) A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16: 685-694
57. Rebmann V., Ven K. van der, Passler M., Pfeiffer K., Krebs D. and Grosse-Wilde H. (2001) Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57: 15-21
58. Hunt J. S., Jadhav L., Chu W., Geraghty D. E. and Ober C. (2000) Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. Gynecol. 183: 682-688
59. Horuzsko A., Lenfant F., Munn D. H. and Mellor A. L. (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int. Immunol. 13: 385-394
60. Aikhionbare F. O., Hodge T., Kuhn L., Bulterys M., Abrams E. J. and Bond V. C. (2001) Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmission. AIDS 15: 2196-2198
61. Fisher S., Genbacev O., Maidji E. and Pereira L. (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and pathogenesis. J. Virol. 74: 6808-6820
62. Castro M. J., Morales P., Rojo-Amigo R., Martinez-Laso J., Allende L., Varela P. et al. (2000) Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens 56: 232-239
63. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J. et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818
64. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L. et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282
65. Colonna M., Samaridis J., Cella M., Angman L., Allen R. L., O'Callaghan C. A. et al. (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096-3100
66. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C. et al. (1999) Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96: 5674-5679
67. Rajagopalan S. and Long E. O. (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1100